Mereo BioPharma (MREO) Times Interest Earned (2023 - 2026)
Mereo BioPharma (MREO) posted quarterly Times Interest Earned of -$42.55 for Q1 2026, up 27.06% year-on-year from -$33.49 in Q1 2025, and down 191.64% on a QoQ basis from -$14.59 in Q4 2025.
Mereo BioPharma (MREO) Times Interest Earned (2023 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has reported Times Interest Earned for 4 consecutive years, with -$42.55 the latest figure, recorded in Q1 2026.
- Quarterly Times Interest Earned rose 27.06% year-over-year to -$42.55 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$27.95 (up 83.29% YoY) and the FY2025 annual result came in at -$0.18, up 19.71% from the prior year.
- Times Interest Earned fell to -$42.55 in Q1 2026 per MREO's latest filing, from -$14.59 in the prior quarter.
- Over the last five years, Times Interest Earned for MREO reached as high as $12.16 in Q4 2023 and fell as low as -$58.34 in Q1 2025.
- A 4-year average of -$16.01 and a median of -$12.95 in 2023 frame the typical range for Times Interest Earned.
- The largest YoY upside for Times Interest Earned was 96.97% in 2024 against a maximum downside of 434.87% in 2024.
- Year by year, Times Interest Earned stood at $12.16 in 2023, then slumped by 434.87% to -$40.73 in 2024, then soared by 64.18% to -$14.59 in 2025, then slumped by 191.64% to -$42.55 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$42.55, -$14.59, and -$2.07 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Mereo BioPharma | 232.52 Mn | 232.52 Mn | - | -42.55 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42.55 |
| Dec 31, 2025 | -14.59 |
| Sep 30, 2025 | -2.07 |
| Jun 30, 2025 | -1.04 |
| Mar 31, 2025 | -58.34 |
| Dec 31, 2024 | -40.73 |
| Sep 30, 2024 | -0.39 |
| Jun 30, 2024 | -0.68 |
| Mar 31, 2024 | -31.94 |
| Dec 31, 2023 | 12.16 |
| Sep 30, 2023 | -12.95 |
| Jun 30, 2023 | -0.79 |
| Mar 31, 2023 | -14.26 |